Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 06/23/2025 3:20:56 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 3558
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
16567
Trolls? We have $7.7mm to do all these trials.
leedom
12/16/2015 12:52:08 PM
16566
The article Dana-Farber submitted about Kevetrin
Drano
12/16/2015 12:44:35 PM
16565
The FUD claims of CTIX needing more money, having
Drano
12/16/2015 12:42:06 PM
16564
Kevetrin does have the long lasting effect of
sox0407
12/16/2015 12:41:29 PM
16561
SOX we are looking at 6+ trials in 2016. $7.7mm
leedom
12/16/2015 12:32:07 PM
16560
Dilutions have been minimal over the years. If
sox0407
12/16/2015 11:59:20 AM
16558
Theory about the U of Bologna Kevetrin trial
Drano
12/16/2015 11:56:41 AM
16554
Attention Mac users: Chrome seems to work much
Drano
12/16/2015 11:42:05 AM
16553
imaginary shares? LMAO! I love the science and
leedom
12/16/2015 11:41:23 AM
16552
All excellent points/info, doubleJ23. The
Drano
12/16/2015 11:39:26 AM
16551
According to articles, good liars try to make
Drano
12/16/2015 11:34:54 AM
16550
Also, even though Leo mentions the ABSSSI market
doubleJ23
12/16/2015 11:28:58 AM
16549
Look if you are going to pretend to own the
F1ash
12/16/2015 11:27:29 AM
16548
There must be something positive about the
sox0407
12/16/2015 11:22:16 AM
16547
Thanks again doubleJ23. I agree that they are
Drano
12/16/2015 11:20:11 AM
16546
So we are down 10% on 250,000
leedom
12/16/2015 11:18:21 AM
16545
That was posted on Yahoo...I guess my assessment
leedom
12/16/2015 11:16:32 AM
16544
Congrats to all of us here who have evidently
Drano
12/16/2015 11:14:42 AM
16543
Thanks for letting us know your other name at
Drano
12/16/2015 11:12:08 AM
16542
Believe me, it was on the tip of my tongue when
doubleJ23
12/16/2015 11:09:12 AM
16541
Thanks for your posts.
ready2rock
12/16/2015 11:06:03 AM
16540
$1.33 well apparently there must be a lot of
leedom
12/16/2015 11:02:42 AM
16539
You may have seen that Solgenix just reported
Drano
12/16/2015 10:49:51 AM
16538
Drano I'm lee122oneill over on the Y board. and
leedom
12/16/2015 10:49:50 AM
16537
That was my guess too. We knew that the bashers
Drano
12/16/2015 10:38:39 AM
16536
Please tell us what name you post under at the
Drano
12/16/2015 10:32:50 AM
16535
You can count on it that someone from the short
Drano
12/16/2015 10:30:29 AM
16534
Your last four posts are all downers. Your posts
thefamilyman
12/16/2015 10:24:36 AM
16533
Somebody keeps bidding for a lot of
grotty
12/16/2015 10:14:16 AM
16532
Science is awesome and Leo has shareholders best
AlanC
12/16/2015 10:08:08 AM
16531
He did not rule it out either. It would depend on
scgmck1
12/16/2015 10:00:37 AM
16530
I bought more at 1.44
grotty
12/16/2015 9:59:47 AM
16529
It was a great meeting and the future is bright
AlanC
12/16/2015 9:59:28 AM
16528
AlanC Science is NO GOOD if you don't have the
leedom
12/16/2015 9:58:02 AM
16527
Your reaction is exactly the reason they would
AlanC
12/16/2015 9:56:12 AM
16526
In all likelihood and Leo agrees Rosen will get a
leedom
12/16/2015 9:56:11 AM
16525
Testing
grotty
12/16/2015 9:55:05 AM
16524
$1.42 Yea great meeting!
leedom
12/16/2015 9:53:41 AM
16523
$1.47 I guess Leo saying no deal until Phase3
leedom
12/16/2015 9:45:16 AM
16522
The support for this site is growing. Similar
AlanC
12/16/2015 9:40:54 AM
16521
Drano: Think about CTIX this way: There are no
AlanC
12/16/2015 9:33:44 AM
16520
I believe it's related to safety studies for
biodoc
12/16/2015 9:28:41 AM
16519
I wonder if he knows about Kevetrin?
leedom
12/16/2015 9:26:49 AM
16518
Welcome thttlpckg. Your concerns are shared here
scgmck1
12/16/2015 9:26:42 AM
16517
Hi Folks, I have just started doing my homework
thttlpckg
12/16/2015 8:37:48 AM
16516
I think the shareholder meeting did exactly what
daydreaming2
12/16/2015 7:49:35 AM
16515
Icon is a small privately held company. Nice to
leedom
12/16/2015 6:22:55 AM
16514
A dude on the other board I'm on asked a great
leedom
12/16/2015 6:21:34 AM
16513
Ihub admin is not impartial and definitely has an
waverunner1
12/16/2015 1:52:18 AM
16512
Icon Bioscience has an intraocular
Drano
12/16/2015 1:11:21 AM
Newer
Older
Recent Articles
Smart Strategies for Borrowing to Pay College Costs
Insights into Warehouse REIT Plc and Relevant Position Disclosures
Explore Exclusive Hospitality Packages for FIFA World Cup 26
Topnotch Crypto Unveils AI Mining V3.0.3 Revolutionizing Mining
LegalZoom's Registered Agent Service Shines in 2025 Ranking
Umecrine Cognition Secures Funding for Clinical Development
Analyzing NVIDIA: Insights on Semiconductor Competitors
Advancements in Quantum Computing: A Milestone for QuEra
Analyzing Microsoft's Performance in the Software Sector
Exploring the Growth of the Anesthesia Monitoring Devices Market
Navigating the New Energy Economy: Utilities Face Modern Challenges
Evaluating Caterpillar's Stock Performance and P/E Ratio
Exploring New Frontiers in Stroke Treatment with RNS60
In-Depth Analysis of Amazon.com in the Retail Market
Hyundai's Commitment to Education and Community Support
TROOPS, Inc. Explores Expansion into Asian Co-working Sector
ABMS Foundation Unveils Research Grant Winners for 2025 Initiative
Investors Find Opportunity in 3D Systems Corporation Lawsuit
Celebrating Excellence: The 2025 Diamond Supplier Awards
Exploring Nuclear Leadership: A Special Event Announcement
Zendesk's Strategic Acquisition: Transforming Customer Analytics
Andrews McMeel Launches Exciting New Coloring Book and Calendar
Crum & Forster's CFO Arleen Paladino Honored for Leadership
CDX Medical Technologies Secures Major Funding to Innovate ECMO
Empowering the Future of Cardiovascular Technology at Octane
New Gene Discoveries in Zebrafish Could Transform Hearing Loss Treatment
Tritax Big Box REIT's Recent Securities Disclosure Insights
Milestone Achieved: Building Completion Certificate Issued
Ascentage Pharma's Successful Pricing of Share Placement
Upcoming Deadline for Centene Corporation Investors: What You Need to Know
Workhorse Stock Faces Challenges Amid Merger Discussions
Blink Charging Expands Reach with Zemetric Acquisition for EVs
How a $100 Investment in Performance Food Group Has Grown
Explore VNBTC's Innovative AI-Driven Approach to Bitcoin Mining
Motto Mortgage Elevate Celebrates Its Grand Opening Event
Exploring the Enchanting Canary Islands With Windstar Cruises
Firstline Brands Announces Exciting New Products for 40th Year
Exploring the Growth and Trends in Respiratory Care Devices
Tennessee Oncology Launches Innovative Cancer Center in Nashville
groundcover's Innovative Approach Earns Recognition in Gartner
Iovance Biotherapeutics Seeks Recovery Amid Leadership Changes
Meme Coins Experience a Remarkable Surge in Value
Nuveen Green Capital and Lone Star PACE Secure $9M Financing
Automotive Properties REIT Announces Upcoming Q2 Financials
Unveiling a Unique Riverfront Residential Development Opportunity
Motto Mortgage Elevate's Grand Opening Marks a New Chapter
Sana Biotechnology's Path to Revolutionize Diabetes Treatment
Exploring Market Sentiment Regarding StepStone Group's Outlook
Understanding Investor Sentiment on SLM Corp's Short Selling Trends
Market Dynamics: Analyzing GE HealthCare Technologies' Short Interest